Midgard Science

Labs / Assays & in vitro testing

ProJect Pharmaceutics

Martinsried, Germany · project-pharmaceutics.com

GMP · GLP

On your own

Free. Their own form.

Contact ProJect Pharmaceutics directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

ProJect Pharmaceutics GmbH develops formulations and manufacturing processes for injectable therapeutic products. It works with recombinant proteins, antibodies, ADCs, peptides, small molecules, viral vectors, liposomes, and nanoparticle systems for preclinical through commercial development. The company is based in Martinsried, Munich, Germany, with business development representation in Boston, MA.

They take quote requests by email.

What they offer

  • Formulation development

    Develops liquid and lyophilized injectable formulations for proteins, antibodies, peptides, ADCs, small molecules, and viral and nanoparticle systems.

  • Preformulation screening

    Screens physicochemical properties and formulation variables to identify stable and developable lead formulations.

  • High concentration & subcutaneous formulation

    Develops high-concentration formulations for subcutaneous delivery.

  • Lyophilization cycle development

    Develops freeze-drying cycles for client formulations and manufacturer equipment.

  • Downstream process development

    Develops purification and UF/DF steps around molecule stability and delivers drug substance in a usable formulation.

  • Analytical services & method development

    Runs and develops analytical methods for biologics, ADCs, cytotoxics, and viral therapeutics, including method implementation and optimization.

  • Forced degradation & stress studies

    Stresses lead formulations to identify degradation pathways and support formulation selection and method development.

  • In-use stability & clinical administration

    Simulates site preparation, dilution, holding, infusion, and injection to assess in-use stability and administration compatibility.

  • Technology transfer to fill & finish

    Develops formulations and fill-finish processes for transfer to a manufacturer’s filling line.

  • Non-GMP toxicology & stability batches

    Makes aseptic non-GMP preclinical batches of liquid or lyophilized product for toxicology, PK/PD, and stability studies.

What they work on

Modalities
Small molecule, Antibody, Bispecific, ADC, Peptide, Viral vector, Recombinant protein, Vaccine, LNP / formulation
Assays and studies
SE-HPLC, AF4, DLS, nanoDSC, CG-MALS, cIEF, icIEF, IEX-HPLC, electrophoresis, light scattering, calorimetry, chromatography, and 1 more
Instruments and platforms
HOF pilot freeze-dryers, Wyatt Technology
Scale and capacity
Up to 1,000 vials per batch, ~1,000 2R vials per biologics batch, 2R to 100H vial sizes, Up to OEB5 cytotoxic containment
Therapeutic areas
biologics, ADCs, cytotoxics, viral therapeutics, live viral vaccines
Turnaround
Within 5 days reporting of analytical results · Within 5 days reporting of results after testing · 2 to 4 weeks from scope alignment to project start · 5 to 6 weeks of cycle development
What to send
Final formulation · Container · Fill volume · Information on your manufacturer’s dryer · Target product profile · Intended manufacturer, if known
Type
CDMO
Sites
Martinsried, Germany · Munich, Germany · Boston, MA, United States
Team
8+ years average scientist tenure
Quality
ICH Q8 · ICH Q5C · ICH Q1A(R2) · ICH Q1B · ICH S6(R1) · GLP-like documentation · Ph. Eur. · USP
Address
manufacturing 250+ short- and long-term stability runs completed 140 lyophili
Founded
2010

Similar labs. Esco Aster, Aurigene Pharmaceutical Services, Sparx BIO, Biofidus GmbH

Found in a contract services directory. Listing built from project-pharmaceutics.com. Work here? Claim this listing.

ProJect Pharmaceutics · Midgard Science